Andreas Machl
Impact in
-
- Barrier Structure and Function Studies
- Neurological Disease Mechanisms and Treatments
-
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 4
- DNA Repair Mechanisms 2
- Molecular Biology Techniques and Applications 2
- Glycosylation and Glycoproteins Research 1
- Oncology 4
- Pancreatic and Hepatic Oncology Research 2
- Colorectal Cancer Treatments and Studies 2
- Co-authors
- Manfred Kubbies (4 shared papers)Suzanne Hosier (1 shared paper)Karen Swisshelm (1 shared paper)Hui Tian (2 shared papers)Bayard R. Huck (2 shared papers)Erik Wilker (2 shared papers)Shomit Sengupta (1 shared paper)Jessica J. Howell (1 shared paper)
- Journals
- Gene (2 papers)Cancer Research (2 papers)Journal for ImmunoTherapy of Cancer (1 paper)Hepatology (1 paper)CPT Pharmacometrics & Systems Pharmacology (1 paper)
- Partner nations
- United StatesGermanyJapan
In The Last Decade
Andreas Machl
13 papers receiving 230 citations
Peers
Comparison fields: 5 of 55
- Neurology 47
- Cancer Research 43
- Oncology 53
- Molecular Biology 123
- Immunology 27
Countries citing papers authored by Andreas Machl
This map shows the geographic impact of Andreas Machl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Machl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Machl more than expected).
Fields of papers citing papers by Andreas Machl
This network shows the impact of papers produced by Andreas Machl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Machl. The network helps show where Andreas Machl may publish in the future.
Co-authors
The 25 scholars most cited alongside Andreas Machl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 71 | |
| 2 | 2023 | 37 | |
| 3 | 2019 | 36 | |
| 4 | M2698 is a potent dual-inhibitor of p70S6K and Akt that affects tumor growth in mouse models of cancer and crosses the blood-brain barrier. | 2016 | 24 |
| 5 | 2022 | 17 | |
| 6 | 2000 | 16 | |
| 7 | 2024 | 13 | |
| 8 | 1998 | 9 | |
| 9 | 2023 | 5 | |
| 10 | 1997 | 3 | |
| 11 | Abstract #3698: Efficacy of MEK inhibitor AS703026 in various primary tumor explants. | 2009 | 2 |
| 12 | 1998 | 2 | |
| 13 | 2014 | 1 |
About Andreas Machl
Andreas Machl is a scholar working on Molecular Biology, Oncology, Surgery, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 13 papers that have together received 236 indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (4 papers), DNA Repair Mechanisms (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), Molecular Biology Techniques and Applications (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Cardiomyopathy and Myosin Studies (1 paper) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Neurology (47 citations), Cancer Research (43 citations), Oncology (53 citations), Molecular Biology (123 citations) and Immunology (27 citations). Andreas Machl has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Manfred Kubbies, Suzanne Hosier, Karen Swisshelm, Hui Tian, Bayard R. Huck, Erik Wilker, Shomit Sengupta, Jessica J. Howell, Lisa Molz and Xiaohong Liu. Their work appears in journals such as Gene, Cancer Research, Journal for ImmunoTherapy of Cancer, Hepatology and CPT Pharmacometrics & Systems Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.